LifeGuard Health Launches New CARDIOPLUS Omega Benefits
CardiaBeat is a novel combination of plant sterols and Omega-3 fatty acids (EPA and DHA) in which the Omega-3s are conjugated to plant sterols to offer broader cardiovascular benefit.
05/12/07 LifeGuard Health and Israeli based biotech company Enzymotec have announced the launch of a new advanced Omega-3 based product. The new product, CARDIOPLUS Omega Benefits, combines LifeGuard’s high EPA ratio Omega-3 fatty acids with Enzymotec’s CardiaBeat product. This combination creates a leading edge product that offers a comprehensive approach to improving the lipid profile.
CardiaBeat is a novel combination of plant sterols and Omega-3 fatty acids (EPA and DHA) in which the Omega-3s are conjugated to plant sterols to offer broader cardiovascular benefit. Earlier this year, it had won the NutrAward for best new ingredient.
“Life Gurad’s new CardioPlus product includes Omega 3 oils in 3:1 ratio for EPA to DHA in a high purity triglyceride form. These two elements provide greater cardiovascular benefits due to the anti-inflammatory properties of EPA said Dr. Micahel Gross, LifeGuard’s CMO. “The addition of CardiaBeat to this specialized Omega 3 fish oil, creates the finest cardio-protective product available and further strengthens our commitment to providing the highest quality, medically based products” concludes Dr. Gross.
Life Guard is an emerging player of condition-specific products through a physician based distribution channel. A close integration with physician partners enables Life Guard to tailor specific products for particular medical specialties.
